Oncorus, Inc.
ONCRDelisted Jul 10, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001671818
Oncorus, Inc. was delisted on Jul 10, 2023; its insiders filed their last Form 4 on Dec 30, 2022; 32 institutions reported holding it in 13F filings for Q1 2023, worth $3.78M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Oncorus, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- −5 vs. Q2 2022
- Shares held
- 16.5M
- −455.7K (−2.7%) vs. Q2 2022
- Total value
- $14.1M
- −$7.36M (−34.4%) vs. Q2 2022
- New holders
- 3
- 6 more added
- Sold out
- 8
- 18 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ONCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 1 | $3 |
| Q2 2023 | 4 | $212.1K |
| Q1 2023 | 32 | $3.78M |
| Q4 2022 | 33 | $3.95M |
| Q3 2022 | 40 | $14.1M |
| Q2 2022 | 45 | $21.4M |
| Q1 2022 | 56 | $34.5M |
| Q4 2021 | 56 | $107.1M |
| Q3 2021 | 48 | $186.2M |
| Q2 2021 | 50 | $282.6M |
| Q1 2021 | 57 | $278.2M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Oncorus, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 491 | $0 | 0.00% | −1,635−76.9% | Reduced |
| FMR LLC | 83 | $0 | 0.00% | −663−88.9% | Reduced |
| Wells Fargo & Company | 129 | $0 | 0.00% | +16+14.2% | Added |
| Royal Bank of Canada | 225 | $0 | 0.00% | +95+73.1% | Added |
| Your Advocates Ltd., LLP | 100 | $0 | 0.00% | 00.0% | Unchanged |
| China Universal Asset Management Co., Ltd. | 243 | $0 | 0.00% | +243 | New |
| BNP Paribas Arbitrage, SA | 905 | $769 | 0.00% | +905 | New |
| JPMorgan Chase & Co | 1,306 | $1.00K | 0.00% | +310+31.1% | Added |
| UBS Group AG | 3,604 | $3.00K | 0.00% | −4,412−55.0% | Reduced |
| Barclays PLC | 10,361 | $9.00K | 0.00% | −639−5.8% | Reduced |
| Tower Research Capital LLC (TRC) | 11,157 | $9.00K | 0.00% | +2,855+34.4% | Added |
| Bank of America Corp | 12,762 | $11.0K | 0.00% | −18,358−59.0% | Reduced |
| Assenagon Asset Management S.A. | 13,642 | $12.0K | 0.00% | +13,642 | New |
| Morgan Stanley | 15,389 | $13.0K | 0.00% | −28,109−64.6% | Reduced |
| Qube Research & Technologies Ltd | 15,874 | $13.0K | 0.00% | −2,000−11.2% | Reduced |
| Goldman Sachs Group Inc | 24,411 | $21.0K | 0.00% | −93,514−79.3% | Reduced |
| HSBC Holdings PLC | 26,420 | $22.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 28,960 | $24.0K | 0.00% | 00.0% | Unchanged |
| Sawtooth Solutions, LLC | 36,748 | $31.0K | 0.00% | −40,588−52.5% | Reduced |
| SG Americas Securities, LLC | 36,337 | $31.0K | 0.00% | +23+0.1% | Added |
| Letko, Brosseau & Associates Inc | 59,150 | $50.0K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 67,300 | $57.0K | 0.00% | −16,000−19.2% | Reduced |
| Bank of New York Mellon Corp | 66,995 | $57.0K | 0.00% | −300.0% | Reduced |
| State Street Corp | 70,135 | $60.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 81,492 | $69.0K | 0.00% | −19,500−19.3% | Reduced |
| Ergoteles LLC | 86,135 | $73.0K | 0.00% | −12,465−12.6% | Reduced |
| Two Sigma Advisers, LP | 108,100 | $92.0K | 0.00% | −42,600−28.3% | Reduced |
| We Are One Seven, LLC | 116,389 | $98.0K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 138,226 | $117.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 209,533 | $178.0K | 0.00% | −7,917−3.6% | Reduced |
| BlackRock Inc. | 272,364 | $231.0K | 0.00% | −6,376−2.3% | Reduced |
| Millennium Management LLC | 368,026 | $313.0K | 0.00% | −9,706−2.6% | Reduced |
| Vanguard Group Inc | 496,314 | $422.0K | 0.00% | −56,326−10.2% | Reduced |
| Sphera Funds Management Ltd. | 540,258 | $459.0K | 0.08% | 00.0% | Unchanged |
| Fosun International Ltd | 962,323 | $818.0K | 0.15% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,914,594 | $1.63M | 0.00% | +23,002+1.2% | Added |
| CHI Advisors LLC | 2,367,436 | $2.01M | 0.54% | 00.0% | Unchanged |
| MPM Oncology Impact Management LP | 2,377,031 | $2.02M | 0.48% | 00.0% | Unchanged |
| MPM Asset Management LLC | 2,849,464 | $2.42M | 0.92% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 3,148,977 | $2.68M | 0.05% | 00.0% | Unchanged |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −81,304−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −41,192−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,868−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −1,629−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −203−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −605−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −121−100.0% | Sold out |